Immunocore Holdings plc Peo Actually Paid Comp Amt
Immunocore Holdings plc (IMCR) reported Peo Actually Paid Comp Amt of $12.16 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-16.
Financial Statements › Cash Flow › Other Cash Flow Items
ecd:PeoActuallyPaidCompAmt · last filed 2026-04-16
| Period end | Peo Actually Paid Comp Amt 12 month |
|---|---|
| 2025-12-31 | $12.16M DEF 14A · filed 2026-04-16 |
| 2024-12-31 | -$21.44M DEF 14A · filed 2026-04-16 |
| 2023-12-31 | $21.97M DEF 14A · filed 2026-04-16 |
| 2022-12-31 | $51.27M DEF 14A · filed 2026-04-16 |
| 2021-12-31 | $71.31M DEF 14A · filed 2026-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |